These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 33444720)

  • 1. Network pharmacology combined with metabolomics to study the mechanism of Shenyan Kangfu Tablets in the treatment of diabetic nephropathy.
    Wang X; He Q; Chen Q; Xue B; Wang J; Wang T; Liu H; Chen X
    J Ethnopharmacol; 2021 Apr; 270():113817. PubMed ID: 33444720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The key role of Shenyan Kangfu tablets, a Chinese patent medicine for diabetic nephropathy: study protocol for a randomized, double-blind and placebo-controlled clinical trial.
    Wang H; Mu W; Zhai J; Xing D; Miao S; Wang J; Deng Y; Wang N; Chen H; Yang H; He X; Shang H
    Trials; 2013 Jun; 14():165. PubMed ID: 23738508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shenyan Kangfu tablet alleviates diabetic kidney disease through attenuating inflammation and modulating the gut microbiota.
    Chen Q; Ren D; Wu J; Yu H; Chen X; Wang J; Zhang Y; Liu M; Wang T
    J Nat Med; 2021 Jan; 75(1):84-98. PubMed ID: 32997272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the potential mechanism of Qingxin Lianzi Yin Decoction on renoprotection in db/db mice via network pharmacology and metabolomics.
    Gao WY; Tian MY; Li ML; Gao SR; Wei XL; Gao C; Zhou YY; Li T; Wang HJ; Bian BL; Si N; Zhao W; Zhao HY
    Phytomedicine; 2024 Apr; 126():155222. PubMed ID: 38382279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
    Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
    J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
    Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies.
    Gao W; Gao S; Zhang Y; Wang M; Liu Y; Li T; Gao C; Zhou Y; Bian B; Wang H; Wei X; Sato T; Si N; Zhao W; Zhao H
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117073. PubMed ID: 37619856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Network Meta-analysis of Qi-supplementing and Yin-nourishing Chinese patent medicines in treatment of early diabetic nephropathy].
    Wang WR; Zhang XM; Li JX; Yang JY; Yu RH; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(14):3949-3964. PubMed ID: 37475086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice.
    Tang D; He WJ; Zhang ZT; Shi JJ; Wang X; Gu WT; Chen ZQ; Xu YH; Chen YB; Wang SM
    Phytomedicine; 2022 Jan; 95():153777. PubMed ID: 34815154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy.
    Dong Y; Zhao Q; Wang Y
    Sci Rep; 2021 Sep; 11(1):19496. PubMed ID: 34593896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The integrated study on the chemical profiling and in vivo course to explore the bioactive constituents and potential targets of Chinese classical formula Qingxin Lianzi Yin Decoction by UHPLC-MS and network pharmacology approaches.
    Gao WY; Si N; Li ML; Gu XR; Zhang Y; Zhou YY; Wang HJ; Wei XL; Bian BL; Zhao HY
    J Ethnopharmacol; 2021 May; 272():113917. PubMed ID: 33609729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Underlying Mechanism of Shenyankangfu Tablet in the Treatment of Glomerulonephritis Through Network Pharmacology, Machine Learning, Molecular Docking, and Experimental Validation.
    Jin M; Ren W; Zhang W; Liu L; Yin Z; Li D
    Drug Des Devel Ther; 2021; 15():4585-4601. PubMed ID: 34785888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.
    Guo MF; Dai YJ; Gao JR; Chen PJ
    J Diabetes Res; 2020; 2020():5947304. PubMed ID: 32215271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network Pharmacology Analysis of ZiShenWan for Diabetic Nephropathy and Experimental Verification of Its Anti-Inflammatory Mechanism.
    Guo X; Wu Y; Zhang C; Wu L; Qin L; Liu T
    Drug Des Devel Ther; 2021; 15():1577-1594. PubMed ID: 33883881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic study of the protective effect of Gandi capsule for diabetic nephropathy.
    Liu Y; Chen X; Liu Y; Chen T; Zhang Q; Zhang H; Zhu Z; Chai Y; Zhang J
    Chem Biol Interact; 2019 Dec; 314():108815. PubMed ID: 31499054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of Bushen Tiansui formula on Alzheimer's disease.
    Zhang Z; Yi P; Yang J; Huang J; Xu P; Hu M; Zhang C; Wang B; Peng W
    J Ethnopharmacol; 2020 Mar; 249():112371. PubMed ID: 31683034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated lipidomics, transcriptomics and network pharmacology analysis to reveal the mechanisms of Danggui Buxue Decoction in the treatment of diabetic nephropathy in type 2 diabetes mellitus.
    Sun L; Yang Z; Zhao W; Chen Q; Bai H; Wang S; Yang L; Bi C; Shi Y; Liu Y
    J Ethnopharmacol; 2022 Jan; 283():114699. PubMed ID: 34610419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating metabolomics and network pharmacology to reveal the mechanisms of Delphinium brunonianum extract against nonalcoholic steatohepatitis.
    Zhang K; Yuan Y; Dawa Z; Liu F; Yao Y; Wang M; Zhu C; Lin C
    J Ethnopharmacol; 2022 Jul; 293():115268. PubMed ID: 35398502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic mechanism of PuRenDan for the treatment of diabetic nephropathy: Network pharmacology and experimental verification.
    Niu H; Fan L; Zhao L; Yao R; He X; Lu B; Pang Z
    J Ethnopharmacol; 2022 Jul; 293():115283. PubMed ID: 35427726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revealing active components, action targets and molecular mechanism of Gandi capsule for treating diabetic nephropathy based on network pharmacology strategy.
    Zhang Q; Ye Q; Huang X; Xu A; Liu Y; Qi J; Zhang H; Zhang J
    BMC Complement Med Ther; 2020 Nov; 20(1):362. PubMed ID: 33228635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.